Million Veteran Program Return of Actionable Results
MVP-ROAR
1 other identifier
interventional
112
1 country
1
Brief Summary
The purpose of the Million Veteran Program- Return of Actionable Results (MVP-ROAR) Study is to develop a process to return medically actionable genetic results to living MVP participants nationwide and to determine the impact of doing so on medical management and outcomes and Veteran quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2019
CompletedFirst Posted
Study publicly available on registry
November 26, 2019
CompletedStudy Start
First participant enrolled
February 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 8, 2024
CompletedResults Posted
Study results publicly available
October 16, 2025
CompletedOctober 16, 2025
September 1, 2025
4.5 years
November 20, 2019
September 8, 2025
September 30, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
LDL-C Change
Change in LDL-C after 6 months.
6 months
Secondary Outcomes (2)
LDL-C Target
6 months
Pharmacotherapy
6 months
Other Outcomes (5)
Cascade Testing
6 months
Lifestyle Behaviors
6 months
Quality of Life (Veterans RAND Survey)
6 months
- +2 more other outcomes
Study Arms (2)
Immediate Results
EXPERIMENTALParticipants in the Immediate Results arm will receive their genetic testing results from a genetic counselor at baseline following randomization.
Delayed Results
EXPERIMENTALParticipants in the Delayed Results arm will receive their genetic testing results from a genetic counselor 6 months after randomization.
Interventions
Disclosure of clinically confirmed, medically actionable genetic testing results and post-test genetic counseling session.
Eligibility Criteria
You may qualify if:
- Living enrollee in MVP
- Is identified to have a pathogenic or likely pathogenic variant in the gene(s) of interest in MVP genotype data
You may not qualify if:
- Previously underwent genetic testing for the condition of interest
- Is incarcerated
- Is pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts, 02130-4817, United States
Related Publications (2)
Vassy JL, Brunette CA, Yi T, Assimes TL, Christensen KD, Knowles JW, Sturm AC, Sun YV, Alexander N, Cardellino MP, Harrison A, Gerety HL, Pyatt M, Vered R, Wilson PWF, Natarajan P, Whitbourne SB, Gaziano JM, Muralidhar S, Danowski ME; Veterans Affairs Million Veteran Program. Opportunistic Genomic Screening for Familial Hypercholesterolemia to Improve Low-Density Lipoprotein Cholesterol: A Randomized Clinical Trial. JAMA Netw Open. 2026 Jan 2;9(1):e2549664. doi: 10.1001/jamanetworkopen.2025.49664.
PMID: 41511773DERIVEDVassy JL, Brunette CA, Yi T, Harrison A, Cardellino MP, Assimes TL, Christensen KD, Devineni P, Gaziano JM, Gong X, Hui Q, Knowles JW, Muralidhar S, Natarajan P, Pyarajan S, Sears MG, Shi Y, Sturm AC, Whitbourne SB, Sun YV, Danowski ME; Million Veteran Program. Design and pilot results from the Million Veteran Program Return Of Actionable Results (MVP-ROAR) Study. Am Heart J. 2024 Oct;276:99-109. doi: 10.1016/j.ahj.2024.04.021. Epub 2024 May 17.
PMID: 38762090DERIVED
MeSH Terms
Conditions
Limitations and Caveats
Limitations include: 1. Lower enrollment than planned 2. Baseline LDL-C values were carried forward for 15 participants missing their 6-month value 3. Participants with variants only detectable by sequencing were not included 4. LDL-C is a surrogate endpoint for long-term clinical outcomes
Results Point of Contact
- Title
- Morgan Danowski
- Organization
- VA Boston Healthcare System
Study Officials
- STUDY CHAIR
Jason L Vassy, MD MPH
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 20, 2019
First Posted
November 26, 2019
Study Start
February 27, 2020
Primary Completion
September 8, 2024
Study Completion
September 8, 2024
Last Updated
October 16, 2025
Results First Posted
October 16, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
We will share de-identified individual-level trial data through a data repository housed on a secure VA server and accessible only to outside investigators with IRB and other regulatory approvals. MVP ROAR Study data will also be stored in the VA MVP Central Database.